Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802).

Ychou, M; Raoul, J-L; Douillard, J-Y; Gourgou-Bourgade, S; Bugat, R; Mineur, L; Viret, F; Becouarn, Y; Bouché, O; Gamelin, E; Ducreux, M; Conroy, T; Seitz, J-F; Bedenne, L; Kramar, A.

Ann Oncol ; 20(4): 674-80, 2009 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-19179549

2.

Cost consequences of adjuvant capecitabine, Mayo Clinic and de Gramont regimens for stage III colon cancer in the French setting.

Douillard, J Y; Tilleul, P; Ychou, M; Dufour, P; Perrocheau, G; Seitz, J F; Maes, P; Lafuma, A; Husseini, F.

Oncology ; 72(3-4): 248-54, 2007.

Artículo en Inglés | MEDLINE | ID: mdl-18185019

3.

Docetaxel in combined-modality treatment of inoperable locally or regionally advanced lung cancer.

Scagliotti, Giorgio V; Douillard, J-Y.

Lung Cancer ; 46 Suppl 2: S13-21, 2004 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-15698527

4.

Pharmacokinetics and pharmacodynamics of irinotecan during a phase II clinical trial in colorectal cancer. Pharmacology and Molecular Mechanisms Group of the European Organization for Research and Treatment of Cancer.

Canal, P; Gay, C; Dezeuze, A; Douillard, J Y; Bugat, R; Brunet, R; Adenis, A; Herait, P; Lokiec, F; Mathieu-Boue, A.

J Clin Oncol ; 14(10): 2688-95, 1996 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-8874328

5.

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.

Rougier, P; Bugat, R; Douillard, J Y; Culine, S; Suc, E; Brunet, P; Becouarn, Y; Ychou, M; Marty, M; Extra, J M; Bonneterre, J; Adenis, A; Seitz, J F; Ganem, G; Namer, M; Conroy, T; Negrier, S; Merrouche, Y; Burki, F; Mousseau, M; Herait, P; Mahjoubi, M.

J Clin Oncol ; 15(1): 251-60, 1997 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-8996150

6.

Challenging the platinum combinations: docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non-small cell lung cancer.

Georgoulias, V; Scagliotti, G; Miller, V; Eckardt, J; Douillard, J Y; Manegold, C.

Semin Oncol ; 28(1 Suppl 2): 15-21, 2001 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-11284620

7.

Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice.

Mattson, K; Bosquee, L; Dabouis, G; Le Groumellec, A; Pujol, J L; Marien, S; Stupp, R; Douillard, J Y; Brägas, B; Berille, J; Olivares, R; Le Chevalier, T.

Lung Cancer ; 29(3): 205-16, 2000 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-10996423

8.

Irinotecan and high-dose fluorouracil/leucovorin for metastatic colorectal cancer.

Douillard, J Y.

Oncology (Williston Park) ; 14(12 Suppl 14): 51-5, 2000 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-11200150

9.

Randomized comparison of prophylactic antidiarrheal treatment versus no prophylactic antidiarrheal treatment in patients receiving CPT-11 (irinotecan) for advanced 5-FU-resistant colorectal cancer: an open-label multicenter phase II study.

Ychou, M; Douillard, J Y; Rougier, P; Adenis, A; Mousseau, M; Dufour, P; Wendling, J L; Burki, F; Mignard, D; Marty, M.

Am J Clin Oncol ; 23(2): 143-8, 2000 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-10776974

10.

Chronopharmacokinetics of oral tegafur and uracil in colorectal cancer patients.

Etienne-Grimaldi, M-C; Cardot, J-M; François, E; Renée, N; Douillard, J-Y; Gamelin, E; Milano, G.

Clin Pharmacol Ther ; 83(3): 413-5, 2008 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-17637782

11.

[Monoclonal antibodies in the diagnosis and treatment of hepatic metastases of colo-rectal cancers]. / Apport des anticorps monoclonaux au diagnostic et au traitement des métastases hépatiques des cancers color-rectaux.

Chatal, J F; Douillard, J Y; Lehur, P A; Kremer, M; Curtet, C; Le Mevel, B; Aubry, J.

Ann Chir ; 39(4): 281-3, 1985 May.

Artículo en Francés | MEDLINE | ID: mdl-4026162

12.

[New prospects in the treatment of non-small-cell lung carcinoma (NSCLC): new biological factors]. / Nouvelles perspectives pour le traitement des cancers bronchiques non à petites cellules (CBNPC): les nouveaux facteurs biologiques.

Douillard, J Y.

Rev Pneumol Clin ; 57(5 Pt 2): S46-9, 2001 Nov.

Artículo en Francés | MEDLINE | ID: mdl-11924244

13.

Vinflunine -- an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study.

Bennouna, J; Breton, J-L; Tourani, J-M; Ottensmeier, C; O'Brien, M; Kosmidis, P; Huat, T E; Pinel, M-C; Colin, C; Douillard, J-Y.

Br J Cancer ; 94(10): 1383-8, 2006 May 22.

Artículo en Inglés | MEDLINE | ID: mdl-16641911

14.

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial.

Cassidy, J; Douillard, J-Y; Twelves, C; McKendrick, J J; Scheithauer, W; Bustová, I; Johnston, P G; Lesniewski-Kmak, K; Jelic, S; Fountzilas, G; Coxon, F; Díaz-Rubio, E; Maughan, T S; Malzyner, A; Bertetto, O; Beham, A; Figer, A; Dufour, P; Patel, K K; Cowell, W; Garrison, L P.

Br J Cancer ; 94(8): 1122-9, 2006 Apr 24.

Artículo en Inglés | MEDLINE | ID: mdl-16622438

15.

Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study.

Douillard, J-Y; Gervais, R; Dabouis, G; Le Groumellec, A; D'Arlhac, M; Spaeth, D; Coudert, B; Caillaud, D; Monnier, A; Clary, C; Maury, B; Mornet, M; Rivière, A; Clouet, P; Couteau, C.

Ann Oncol ; 16(1): 81-9, 2005 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-15598943

16.

Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials.

Mitry, E; Douillard, J-Y; Van Cutsem, E; Cunningham, D; Magherini, E; Mery-Mignard, D; Awad, L; Rougier, P.

Ann Oncol ; 15(7): 1013-7, 2004 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-15205193

17.

Metastatic colorectal cancer: integrating irinotecan into combination and sequential chemotherapy.

Douillard, J-Y; Sobrero, A; Carnaghi, C; Comella, P; Díaz-Rubio, E; Santoro, A; Van Cutsem, E.

Ann Oncol ; 14 Suppl 2: ii7-12, 2003.

Artículo en Inglés | MEDLINE | ID: mdl-12810451

18.

Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer.

Douillard, J Y; Bennouna, J; Vavasseur, F; Deporte-Fety, R; Thomare, P; Giacalone, F; Meflah, K.

Cancer Immunol Immunother ; 49(1): 56-61, 2000 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-10782866

19.

Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard.

Saltz, L B; Douillard, J Y; Pirotta, N; Alakl, M; Gruia, G; Awad, L; Elfring, G L; Locker, P K; Miller, L L.

Oncologist ; 6(1): 81-91, 2001.

Artículo en Inglés | MEDLINE | ID: mdl-11161231

20.

Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer.

Le Chevalier, T; Brisgand, D; Soria, J C; Douillard, J Y; Pujol, J L; Ruffie, P; Aberola, V; Cigolari, S.

Oncologist ; 6 Suppl 1: 8-11, 2001.

Artículo en Inglés | MEDLINE | ID: mdl-11181998

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: